Meihua International Medical Technologies Co., Ltd.’s Price-to-Earnings Ratio at a glance
Meihua International Medical Technologies Co., Ltd. reports price-to-earnings ratio of 0.9x for Dec 2024. The prior period recorded 3x (Dec 2023). Year over year the metric moved −2.18 (−71.4%). The rolling three-period average stands at 11.7x. Data last refreshed Nov 20, 2025, 4:19 PM.
Latest reading
0.9x · Dec 2024
YoY movement
−2.18 (−71.4%)
Rolling average
11.7x
Current Price-to-Earnings Ratio
0.9x
−2.18
−71.4%
Rolling average
11.7x
Latest Value
0.9x
Dec 2024
YoY Change
−2.18
Absolute
YoY Change %
−71.4%
Rate of change
3-Period Avg
11.7x
Smoothed
Narrative signal
Meihua International Medical Technologies Co., Ltd.’s price-to-earnings ratio stands at 0.9x for Dec 2024. Year-over-year, the metric shifted by −2.18, translating into a −71.4% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How price-to-earnings ratio shapes Meihua International Medical Technologies Co., Ltd.'s story
As of Dec 2024, Meihua International Medical Technologies Co., Ltd. reports price-to-earnings ratio of 0.9x. Analyze price-to-earnings history, valuation swings, and relative multiples to benchmark market expectations.
Why the P/E ratio matters
The price-to-earnings multiple reveals how much investors are willing to pay for each dollar of net income. Elevated P/E levels suggest strong growth expectations or limited earnings.
Tracking valuation cycles
Monitoring multi-year P/E trends highlights how macro cycles, product launches, or profitability changes impact valuation over time.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
34.4%
Operating Margin
14.8%
Net Profit Margin
11.2%
Return on Equity
6.8%
Return on Assets
5.8%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Meihua International Medical Technologies Co., Ltd. (MHUA) FAQs
Answers tailored to Meihua International Medical Technologies Co., Ltd.’s price-to-earnings ratio profile using the latest Financial Modeling Prep data.
What is Meihua International Medical Technologies Co., Ltd.'s current price-to-earnings ratio?
As of Dec 2024, Meihua International Medical Technologies Co., Ltd. reports price-to-earnings ratio of 0.9x. This reading reflects the latest filings and price data for MHUA.
How is Meihua International Medical Technologies Co., Ltd.'s price-to-earnings ratio trending year over year?
Year-over-year, the figure shifts by −2.18 (−71.4%). Pair this context with revenue growth and free cash flow signals to gauge momentum for MHUA.
Why does price-to-earnings ratio matter for Meihua International Medical Technologies Co., Ltd.?
The P/E ratio compares a company’s share price with its per-share earnings to gauge valuation. For Meihua International Medical Technologies Co., Ltd., operating within Healthcare — Medical - Instruments & Supplies, tracking this metric helps benchmark management's execution against close competitors.
Is Meihua International Medical Technologies Co., Ltd.'s price-to-earnings ratio above its recent average?
Meihua International Medical Technologies Co., Ltd.'s rolling three-period average sits at 11.7x. Comparing the latest reading of 0.9x to that baseline highlights whether momentum is building or fading for MHUA.
How frequently is Meihua International Medical Technologies Co., Ltd.'s price-to-earnings ratio refreshed?
Data for MHUA was last refreshed on Nov 20, 2025, 4:19 PM and updates automatically every 24 hours, keeping your valuation inputs current.